Mitochondrial DNA haplogroup analysis reveals no association between the common genetic lineages and prostate cancer in the Korean population

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Kim, Wook ^a   Yoo, Tag Keun ^b   Shin, Dong Jik ^c   Rho, Hyun Wook ^a   Jin, Han Jun ^a   Kim, Eun Tak ^b   Bae, Yoon Sun ^c  

^a Dankook University   (South Korea)

^b Eulji University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GENETIC LINE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; HAPLOIDY; HAPLOTYPE; HUMAN; HUMAN CELL; KOREA; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PROSTATE CANCER; RISK ASSESSMENT; GENETICS; MUTATION; PROSTATE TUMOR;

DNA, MITOCHONDRIAL; HAPLOTYPES; HUMANS; KOREA; MALE; MUTATION; PROSTATIC NEOPLASMS;

EID: 48249114016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002211     Document Type: Article

References (26)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics. Ca Cancer J Clin 51: 15-36.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al. (2005) Cancer Statistics. Ca Cancer J Clin 55: 10-30.
3. Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, et al. (2000) Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 9: 1335-1341.
4. Sim HG, Cheng CW (2005) Changing demography of prostate cancer in Asia. Eur J Cancer 41: 834-845.
5. Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL (1999) Chromosomal clues to the development of prostate tumors. Prostate 38: 303-312.
6. Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA (2004) Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93: 1139-1150.
7. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ et al. (2005) MtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102: 719-724.
8. Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, et al. (2006) North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 175: 468-473.
9. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, et al. (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72: 804-811.
10. Wallace DC (2005) A mitochondrial paradigm or metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359-407.
11. Jessie BC, Sun CQ Irons HR, Marshall FF, Wallace DC, et al. (2001) Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp Gerontol 37: 169-174.
12. Parr RL, Dakubo GD, Crandall KA, Maki J, Reguly B, et al. (2006) Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology. J Mol Diagn 8: 312-319.
13. Pakendorf B, Stoneking M (2005) Mitochondrial DNA and human evolution. Annu Rev Genomics Hum Genet 6: 165-183.
14. Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, et al. (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144: 1835-1850.
15. Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6: 389-402.
16. Kim W, You TK, Kim SJ, Shin DJ, Tyler-Smith C, et al. (2007) Lack of association between Y-chromosomal haplogroups and prostate cancer in the Korean population. PLoS ONE 2: e172.
17. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A laboratory manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press.
18. Umetsu K, Tanaka M, Yuasa I, Adachi N, Miyoshi A, et al. (2005) Multiplex amplified product-lengLh polymorphism analysis of 36 mitochondrial single-nucleotide polymorphisms for haplogrouping of East Asian populations. Electrophoresis 26: 91-98
19. Derenko MV, Lunkina AV, Maliarchuk BA, Zakharov IA, Tsedev T, et al. (2004) Restriction polymorphism of mitochondrial DNA in Koreans and Mongoilians. Genetika 40: 1562-1570.
20. Kivisild T, Tolk HV, Parik J, Wang Y, Papiha SS, et al. (2002) The emerging limbs and twigs of the East Asian mtDNA tree. Mol Biol Evol 19: 1737-1751.
21. Kong QP, Bandelt HJ, Sun C, Yao YG, Salas A, et al. (2006) Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet 15: 2076-2086.
22. Schneider S, Roessli D, Excoffier L (2000) Arlequin: a software for population genetics data analysis. 2.000 edn, Genetics and Biometry Lab, Dept. of Anthropology, University of Geneva.
23. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, et al. (2005) A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2: e296.
24. Jin HJ, Kwak KD, Hammer MF, Nakahori Y, Shinka T, et al. (2003) Y-chromosomal DNA haplogroups and their implications for the dual origins of the Koreans. Hum Genet 114: 27-35.
25. Paracchini S, Pearce CL, Kolonel LN, Altshuler D, Henderson BE, et al. (2003) A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study. J Med Genet 40: 815-819.
26. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, et al. (2004) Human prostate cancer risk factors. Cancer 101: 2371-2490.